Ceftus Clav 50mg/31.25mg Dry Syrup
Marketer
Tusker Pharma Pvt Ltd
Salt Composition
Cefixime (50mg) + Potassium Clavulanate (31.25mg)
Overview Ceftus Clav 50mg/31.25mg Dry Syrup
Clavulin DS, a 50mg/31.25mg dry syrup formulation, combats bacterial infections by inhibiting microbial growth and spread. This prescription medication requires adherence to the prescribed dosage. It may be taken with or without food, but consistent timing is crucial for optimal effectiveness. Exceeding the recommended dose can be harmful. Missed doses should be taken promptly upon recollection. Complete the entire course of treatment, even with symptom improvement; premature cessation may reduce its efficacy. Common side effects include nausea, vomiting, diarrhea, and indigestion. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) require urgent medical help. Inform your physician of all current medications before use. Pregnant or breastfeeding individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Ceftus Clav 50mg/31.25mg Dry Syrup
No text was provided to rephrase. Please provide the text you wish me to rewrite.
Uses of Ceftus Clav 50mg/31.25mg Dry Syrup
Managing Bacterial Infections
Major Benefits of Ceftus Clav 50mg/31.25mg Dry Syrup:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Consult the product label for complete instructions prior to consumption. Dissolve the powder in sterile water, ensuring thorough mixing before use. Ceftus Clav 50mg/31.25mg Dry Syrup can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Ceftus Clav 50mg/31.25mg Dry Syrup:
- Diarrhea
- Nausea
- Stomach pain
- Indigestion
- Flatulence
How to use Ceftus Clav 50mg/31.25mg Dry Syrup:
Administer this medication according to your physician's prescribed dosage and schedule. Consult the product label for complete instructions prior to consumption. Dissolve the powder in sterile water; shake thoroughly before use. Ceftus Clav 50mg/31.25mg Dry Syrup can be ingested with or without food, although consistent timing is recommended.
How Ceftus Clav 50mg/31.25mg Dry Syrup works:
Ceftus Clav 50mg/31.25mg Dry Syrup unites Cefixime, an antibiotic, with Potassium Clavulanate, a beta-lactamase inhibitor. Cefixime's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. The addition of Potassium Clavulanate overcomes bacterial resistance, thereby boosting Cefixime's antibacterial effectiveness.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ceftus Clav 50mg/31.25mg Dry Syrup lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The oral suspension Ceftus Clav, containing 50mg/31.25mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The combination medication Ceftus Clav, 50mg/31.25mg dry syrup, presents a low risk during breastfeeding. Research in human subjects indicates minimal drug transfer into breast milk, posing no discernible threat to the infant.
DrivingCONSULT YOUR DOCTOR
Ceftus Clav 50mg/31.25mg Dry Syrup's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
The dry syrup formulation of Ceftus Clav (50mg/31.25mg) requires careful administration for individuals with impaired renal function. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Ceftus Clav 50mg/31.25mg Dry Syrup cautiously, as dosage modification may be necessary. Physician consultation is recommended. Liver function should be regularly assessed during treatment.
What if you forget to take Ceftus Clav 50mg/31.25mg Dry Syrup :
Should you forget a dose of Ceftus Clav 50mg/31.25mg Dry Syrup, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ceftus Clav 50mg/31.25mg Dry Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently